The classification of cancer clinical trials typically involves four distinct phases: Phase I, Phase II, Phase III, and Phase IV. The question asks to identify the option that does not fit this standard classification, likely due to an inaccurate description.
Clinical trials for cancer drugs or devices are structured in sequential phases to evaluate safety and efficacy:
The description provided for Phase III trials in Option C is inconsistent with standard clinical trial protocols:
The description in Option C ("Uncontrolled trials after regulatory approvals") more closely resembles the characteristics of Phase IV trials, not Phase III. Standard Phase III trials are crucial for obtaining regulatory approval and are generally controlled and conducted prior to marketing.
Therefore, the incorrect description makes Option C the exception among the standard phases of cancer trials.
| List-I | List-II |
| Electronic Configuration | First Ionisation energy (kJ mol$^{-1}$) |
| (A). ns$^2$ | (I). 2100 |
| (B). ns$^2$np$^1$ | (II). 1400 |
| (C). ns$^2$np$^3$ | (III). 800 |
| (D). ns$^2$np$^6$ | (IV). 900 |
| List-I | List-II |
| Spectroscopy | Property |
| (A). Raman | (I). Polarizability |
| (B). FTIR | (II). Dipole Moment |
| (C). UV-Visible | (III). Absorbance |
| (D). NMR | (IV). Spin |